57 related articles for article (PubMed ID: 28268188)
21. Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model.
Ruiz-Rodado V; Dowdy T; Lita A; Kramp T; Zhang M; Shuboni-Mulligan D; Herold-Mende C; Armstrong TS; Gilbert MR; Camphausen K; Larion M
Front Oncol; 2022; 12():979537. PubMed ID: 36353533
[TBL] [Abstract][Full Text] [Related]
22. Effects of Methylphenidate on the Dopamine Transporter and Beyond.
Zetterström TSC; Quansah E; Grootveld M
Curr Top Behav Neurosci; 2022; 57():127-157. PubMed ID: 35507284
[TBL] [Abstract][Full Text] [Related]
23. Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased
Percival BC; Latour YL; Tifft CJ; Grootveld M
Cells; 2021 Mar; 10(3):. PubMed ID: 33807817
[TBL] [Abstract][Full Text] [Related]
24. Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites.
Chan SY; Probert F; Radford-Smith DE; Hebert JC; Claridge TDW; Anthony DC; Burnet PWJ
Sci Rep; 2020 Oct; 10(1):16857. PubMed ID: 33033375
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma.
Ruiz-Rodado V; Seki T; Dowdy T; Lita A; Zhang M; Han S; Yang C; Cherukuri MK; Gilbert MR; Larion M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575619
[TBL] [Abstract][Full Text] [Related]
26. Diminished Myoinositol in Ventromedial Prefrontal Cortex Modulates the Endophenotype of Impulsivity.
Jupp B; Sawiak SJ; van der Veen B; Lemstra S; Toschi C; Barlow RL; Pekcec A; Bretschneider T; Nicholson JR; Robbins TW; Dalley JW
Cereb Cortex; 2020 May; 30(5):3392-3402. PubMed ID: 31897490
[TBL] [Abstract][Full Text] [Related]
27. Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response.
da Silva BS; Leffa DT; Beys-da-Silva WO; Torres ILS; Rovaris DL; Victor MM; Rohde LA; Mota NR; Oliveira C; Berger M; Yates JR; Sabnis R; Peña RD; Campos AR; Grevet EH; Santi L; Bau CHD; Contini V
Transl Psychiatry; 2019 Nov; 9(1):308. PubMed ID: 31740662
[TBL] [Abstract][Full Text] [Related]
28. PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.
Stevens T; Sangkuhl K; Brown JT; Altman RB; Klein TE
Pharmacogenet Genomics; 2019 Aug; 29(6):136-154. PubMed ID: 30950912
[No Abstract] [Full Text] [Related]
29. The Relationship between Food Insecurity and Symptoms of Attention-Deficit Hyperactivity Disorder in Children: A Summary of the Literature.
Lu S; Perez L; Leslein A; Hatsu I
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30893802
[TBL] [Abstract][Full Text] [Related]
30. Methylphenidate disrupts cytoskeletal homeostasis and reduces membrane-associated lipid content in juvenile rat hippocampus.
Schmitz F; Pierozan P; Biasibetti-Brendler H; Ferreira FS; Dos Santos Petry F; Trindade VMT; Pessoa-Pureur R; Wyse ATS
Metab Brain Dis; 2018 Jun; 33(3):693-704. PubMed ID: 29288365
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.
Frölich J; Banaschewski T; Döpfner M; Görtz-Dorten A
Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1169-83. PubMed ID: 24856438
[TBL] [Abstract][Full Text] [Related]
32. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
Quinn D
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
[TBL] [Abstract][Full Text] [Related]
33.
Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
[TBL] [Abstract][Full Text] [Related]
34. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
Quansah E; Zetterström TSC
Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
[TBL] [Abstract][Full Text] [Related]
35. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence.
Adriani W; Canese R; Podo F; Laviola G
Neurotoxicol Teratol; 2007; 29(1):116-25. PubMed ID: 17196789
[TBL] [Abstract][Full Text] [Related]
36. Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study.
Hammerness P; Biederman J; Petty C; Henin A; Moore CM
CNS Neurosci Ther; 2012 Jan; 18(1):34-40. PubMed ID: 21143432
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
